Former Charleston Naval Base Land Exchange Act of 2009
Legislative Progress
Introduced
September 29, 2010
Latest Action
September 29, 2010
Primary Sponsor
Lindsey GrahamRepublican(SC)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 4,048 other S bills in the 111th — cohort avg 29d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2012 · first_quarter · Health Issues
Policy issues relating to Patient Protection and Affordable Care Act (Public Law 111-148) implementation, including the medical device tax (S. 17 and H.R. 436); Accountable Care Organizations; the Independent Payment Advisory Board (H.R. 452); and comparative effectiveness research. Also, policy issues related to the FDA's 510(k) regulatory proposals and reauthorization of the Medical Device User Fee and Modernization Act. H.R. 3209, Premarket Predictability Act. H.R. 3208, Patients Come First Act. H.R. 3214/S. 1972, Food and Drug Administration Mission Reform Act. H.R. 3230, Keeping America Competitive through Harmonization Act. H.R. 3847, Safety of Untested and New Devices Act. S. 1700, Medical Device Regulatory Improvement Act. S. 1865, Patient Access to Medical Innovation Act. S. 1995, Medical Device Patient Safety Act.
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2011 · fourth_quarter · Health Issues
Policy issues relating to Patient Protection and Affordable Care Act (Public Law 111-148) implementation, including the medical device tax (S. 17 and H.R. 436); Accountable Care Organizations; the Independent Payment Advisory Board (H.R. 452); and comparative effectiveness research. Also, policy issues related to the FDA's 510(k) regulatory proposals and reauthorization of the Medical Device User Fee and Modernization Act.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · fourth_quarter · Taxation/Internal Revenue Code
International tax issues regarding intangibles and territorial tax reform. S.17/HR 436: Support repeal of Medical Device Tax.
Client expense: $160,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE